The UDP-glycosyltransferase (UGT) superfamily: new members, new functions, and novel paradigms

R Meech, DG Hu, RA McKinnon… - Physiological …, 2019 - journals.physiology.org
UDP-glycosyltransferases (UGTs) catalyze the covalent addition of sugars to a broad range
of lipophilic molecules. This biotransformation plays a critical role in elimination of a broad …

Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons

T Shimada - Drug metabolism and pharmacokinetics, 2006 - jstage.jst.go.jp
Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous environmental carcinogens and
metabolized by a variety of xenobiotic-metabolizing enzymes such as cytochrome P450 …

Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group

KS Albain, JM Unger, JJ Crowley… - JNCI: Journal of the …, 2009 - academic.oup.com
Background Racial disparities in cancer outcomes have been observed in several
malignancies. However, it is unclear if survival differences persist after adjusting for clinical …

Pharmacogenomics of human UDP-glucuronosyltransferase enzymes

C Guillemette - The pharmacogenomics journal, 2003 - nature.com
ABSTRACT UDP-glucuronosyltransferase (UGT) enzymes comprise a superfamily of key
proteins that catalyze the glucuronidation reaction on a wide range of structurally diverse …

Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in …

K Kurose, E Sugiyama, Y Saito - Drug metabolism and …, 2012 - jstage.jst.go.jp
Drug lag, recently discussed extensively in Japan, can be divided into two phases: clinical
development time and application review time. The former factor is still an important problem …

Hyperbilirubinemia syndromes (Gilbert-Meulengracht, crigler-najjar, dubin-johnson, and rotor syndrome)

CP Strassburg - Best Practice & Research Clinical Gastroenterology, 2010 - Elsevier
Hyperbilirubinemia is an important clinical sign that often indicates severe hepatobiliary
disease of different etiologies. Inherited non-haemolytichyperbilirubinemic conditions …

Coordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2

C Köhle, KW Bock - Biochemical pharmacology, 2007 - Elsevier
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor with important
roles in metabolic adaptation, normal physiology and dioxin toxicology. Metabolic …

Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility

MM De Jong, IM Nolte, GJ Te Meerman… - Journal of medical …, 2002 - jmg.bmj.com
This review focuses on genes other than the high penetrance genes BRCA1 and BRCA2
that are involved in breast cancer susceptibility. The goal of this review is the discovery of …

Glucuronidation and the UDP-glucuronosyltransferases in health and disease

PG Wells, PI Mackenzie, JR Chowdhury… - Drug metabolism and …, 2004 - ASPET
This article is an updated report of a symposium held at the June 2000 annual meeting of
the American Society for Pharmacology and Experimental Therapeutics in Boston. The …

The heme catabolic pathway and its protective effects on oxidative stress‐mediated diseases

L Vítek, HA Schwertner - Advances in clinical chemistry, 2007 - Elsevier
Bilirubin, the principal bile pigment, is the end product of heme catabolism. For many years,
bilirubin was thought to have no physiological function other than that of a waste product of …